Hypophosphite Methanogenesis Inhibition in Complex Microbial Communities
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current inhibitors of microbial methanogenesis are limited in number, non-specific, and require high concentrations, and existing methods do not effectively address complex microbial communities or environmental systems.
Innovation Solution
Utilization of hypophosphite, a formate analog, to selectively inhibit syntrophic methanogenesis in complex microbial communities, and engineering plants to express a hypophosphite/2-oxoglutarate dioxygenase gene to utilize hypophosphite as a phosphorus source while inhibiting methanogenesis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional inhibitors (BES, 3-NOP, lumazine) are used to inhibit methanogenesis, then methanogenesis is inhibited, but high concentrations are required and they are non-specific
Solution Approach 1:
The patent changes the chemical structure parameter of the inhibitor from conventional compounds (BES, 3-NOP, lumazine) to hypophosphite, which has different molecular properties that enable effective inhibition at much lower concentrations. This structural parameter change resolves the contradiction by achieving reliable inhibition without requiring high quantities of the substance.
Solution Approach 2:
The patent applies local quality by designing an inhibitor with specific molecular characteristics (hypophosphite) that target particular aspects of methanogenesis pathways. The inhibitor's specific chemical properties enable it to interact with key enzymes in the methanogenesis process, providing reliable inhibition at low concentrations rather than requiring high doses of non-specific conventional inhibitors.
2Reliability
If conventional inhibitors are used, then methanogenesis is inhibited, but the inhibitors are non-specific and affect broad microbial populations
Solution Approach 1:
The patent applies local quality by designing an inhibitor with specific molecular characteristics (hyperphosphite) that target particular aspects of methanogenesis pathways. The inhibitor's specific chemical properties enable it to interact with key enzymes in the methanogenesis process, providing reliable inhibition at low concentrations rather than requiring high doses of non-specific conventional inhibitors.
Solution Approach 2:
The patent uses hypophosphite as an intermediary substance that mediates inhibition of methanogenesis through specific biochemical interactions with formate metabolic enzymes. This intermediary approach allows selective targeting of methanogenic pathways without broadly affecting other microbial populations, resolving the contradiction between effectiveness and specificity.
3Reliability
If high concentrations of conventional inhibitors are used, then methanogenesis is inhibited, but production costs increase
Solution Approach 1:
The patent changes the chemical structure parameter of the inhibitor from conventional compounds to hypophosphite, which achieves effective inhibition at much lower concentrations. This parameter change directly reduces the quantity of inhibitor needed, thereby lowering production costs while maintaining reliable inhibition effectiveness.
Solution Approach 2:
The patent employs hypophosphite as a cost-effective inhibitor that requires low concentrations for effective action. By using a substance that is both cheap to produce and highly potent at low doses, the patent resolves the contradiction between achieving reliable inhibition and minimizing production costs.
4Reliability
If conventional inhibitors are applied in environmental systems, then some methanogenesis inhibition occurs, but they are not viable for complex microbial communities
Solution Approach 1:
The patent uses hypophosphite as an intermediary substance that mediates inhibition of methanogenesis through specific biochemical interactions with formate metabolic enzymes. This intermediary approach allows selective targeting of methanogenic pathways in complex environmental microbial communities without broadly affecting other microbial populations, resolving the contradiction between effectiveness and applicability to environmental systems.
Solution Approach 2:
The patent changes the chemical and dosing parameters of the inhibition approach by using hypophosphite at low concentrations. This parameter change enables effective application in complex environmental systems where conventional high-concentration inhibitors would be non-viable, achieving both reliability and environmental adaptability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Hypophosphite effectively inhibits methanogenesis in diverse environments and agricultural systems, providing a wide therapeutic window and dual benefits as a phosphorus source, enhancing carbon storage and mitigating methane emissions.
Implementation Method 1
Hypophosphite is a formate analog and competitive inhibitor of formate metabolic enzymes
Implementation Method 2
Both phosphite and hypophosphite must be oxidized to phosphate to serve as phosphorus sources
Implementation Method 3
engineering a plant to comprise and express a heterologous hypophosphite/2-oxoglutarate dioxygenase htxa gene to enable the use of the reduced phosphorus, such as hypophosphite as a phosphorus source
Data Source
AI summary
Hypophosphite is used to inhibit syntrophic methanogenesis or growth of hydrogenotrophic methanogens, plants are genetically engineered to comprise and express a heterologous hypophosphite/2-oxoglutarate dioxygenase htxa gene to enable the use of the reduced phosphorus, such as hypophosphite as a phosphorus source, and hypophosphite and phosphite fertilizer amendments are utilized as phosphorus sources by soil microorganisms, to increase carbon storage in deep sediments.